Chen YJ - Search Results

1

A new auronol from Cudrania cochinchinensis.

Lin CF, Chen YJ, Huang YL, Chiou WF, Chiu JH, Chen CC. Lin CF, et al. Among authors: chen cc, chen yj. J Asian Nat Prod Res. 2012;14(7):704-7. doi: 10.1080/10286020.2012.682305. Epub 2012 May 15. J Asian Nat Prod Res. 2012. PMID: 22582907

2

1,3,5-trihydroxy-4-prenylxanthone represses lipopolysaccharide-induced iNOS expression via impeding posttranslational modification of IRAK-1.

Chiou WF, Chen CC, Lin IH, Chiu JH, Chen YJ. Chiou WF, et al. Among authors: chen cc, chen yj. Biochem Pharmacol. 2011 Mar 15;81(6):752-60. doi: 10.1016/j.bcp.2010.12.022. Epub 2011 Jan 11. Biochem Pharmacol. 2011. PMID: 21232528

3

Prognostic effects and regulation of activin A, maspin, and the androgen receptor in upper urinary tract urothelial carcinoma.

Rau KM, Chen YJ, Sun MT, Kang HY. Rau KM, et al. Among authors: chen yj. Anticancer Res. 2011 May;31(5):1713-20. Anticancer Res. 2011. PMID: 21617230

4

High p16 expression predicts a positive response to chemoradiotherapy in stage IVa/b head and neck squamous cell carcinoma.

Chen YJ, Rau KM, Chien CY, Fang FM, Huang TL, Chiu TJ. Chen YJ, et al. Asian Pac J Cancer Prev. 2011;12(3):649-55. Asian Pac J Cancer Prev. 2011. PMID: 21627359 Free article.

5

Midkine neurite growth-promoting factor 2 expression as a potential prognostic marker of adjuvant therapy in head and neck squamous cell carcinoma.

Chiu TJ, Chen YJ, Rau KM, Chen CH, Chien CY, Li SH, Tsai HT, Eng HL. Chiu TJ, et al. Among authors: chen yj, chen ch. Biomarkers. 2013 Dec;18(8):687-98. doi: 10.3109/1354750X.2013.846412. Epub 2013 Oct 28. Biomarkers. 2013. PMID: 24164595

6

Intraarterial Cisplatin and intravenous adriamycin in nonmetastatic osteosarcoma of the extremities: a single institution experience in Taiwan.

Chiu TJ, Wang JW, Chen YJ, Tang Y, Huang CH. Chiu TJ, et al. Among authors: chen yj. Chang Gung Med J. 2009 Jan-Feb;32(1):72-80. Chang Gung Med J. 2009. PMID: 19292942 Free article.

7

miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutation.

Chou CK, Chen RF, Chou FF, Chang HW, Chen YJ, Lee YF, Yang KD, Cheng JT, Huang CC, Liu RT. Chou CK, et al. Among authors: chen yj, chen rf. Thyroid. 2010 May;20(5):489-94. doi: 10.1089/thy.2009.0027. Thyroid. 2010. PMID: 20406109

8

No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan.

Liu RT, Chen YJ, Chou FF, Li CL, Wu WL, Tsai PC, Huang CC, Cheng JT. Liu RT, et al. Among authors: chen yj. Clin Endocrinol (Oxf). 2005 Oct;63(4):461-6. doi: 10.1111/j.1365-2265.2005.02367.x. Clin Endocrinol (Oxf). 2005. PMID: 16181240

9

Osteopontin Involves Cisplatin Resistance and Poor Prognosis in Oral Squamous Cell Carcinoma.

Luo SD, Chen YJ, Liu CT, Rau KM, Chen YC, Tsai HT, Chen CH, Chiu TJ. Luo SD, et al. Among authors: chen yj, chen ch, chen yc. Biomed Res Int. 2015;2015:508587. doi: 10.1155/2015/508587. Epub 2015 Sep 30. Biomed Res Int. 2015. PMID: 26491674 Free PMC article. Clinical Trial.

10

Metastatic eccrine porocarcinoma detected on FDG PET/CT.

Li SH, Chen MT, Chen YJ, Wang SL, Chang-Yu W. Li SH, et al. Among authors: chen yj, chen mt. Clin Nucl Med. 2007 Sep;32(9):743-5. doi: 10.1097/RLU.0b013e3181250309. Clin Nucl Med. 2007. PMID: 17710036

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,286 results

Search Page